To Subscribe to our free online Stock market updates ,you can visit our website : http://www.pennystockpickreport.com/
Bristol Myers Squibb Co. (NYSE:BMY) surges 2.19% to $25.69 on 11.58 million shares. The stock is up over 56% from its 52-week low and has a market capitalization of $49.80 billion. In the last six months the stock went up over 28%. Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical and nutritional products. The Company had two segments: Pharmaceuticals and Nutritionals.
La Jolla Pharmaceutical Company (NASDAQ:LJPC) is up 110.65% to $0.127 on 12.01 million shares after the company announced that it has entered into a definitive merger agreement with Adamis Pharmaceuticals Corporation on December 4, 2009. Upon closing, the combined company will focus on the development and commercialization of therapeutic products for a variety of viral diseases, including hepatitis and influenza. It is anticipated that the merged company will be named Adamis Pharmaceuticals Corporation and be headquartered in
Keryx Biopharmaceuticals (NASDAQ:KERX) went up 7.42% to $3.33 on 2.50 million shares after AEterna Zentaris Inc. announced that its partner Keryx Biopharmaceuticals reported updated efficacy and safety data as well as new survival data on the clinical activity of perifosine (KRX-0401) in combination with bortezomib (Velcade) (+/- dexamethasone) in patients with relapsed/refractory multiple myeloma.